Barely Significant

Excerpts

514,629 sentences

highly significantP = 0.0070.1× alphaqualifiedgold
Meta‐analysis has shown a highly significant relationship ( P = 0.007 OR 1.52) between hospitalization for respiratory syncytial virus (RSV) bronchiolitis and possession of a minor allele for a vitamin D receptor polymorphism (Fok1‐f rs2228570) that lowers transcriptional activity of the vitamin D receptor [ 51 ].
showed a trendp = .0070.1× alpha
Patients with MAPT mutations showed a trend towards more severe atrophy in left entorhinal cortex (U = 2.0, z = −2.68, p = .007) and fusiform gyrus (U = 1.5, z = −2.72, p = .006) and right perirhinal cortex (U = 1.5, z = −2.67, p = .007) than patients with mutations in the GRN and C9orf72 gene and in right fusiform gyrus compared to bvFTD patients with no gene mutation (U = 13.0, z = −2.80, p = .005). 4 Discussion In this large cohort of bvFTD patients naming problems were a prominent feature of many, although not all, patients (around 50%).
highly significantp=0.0070.1× alphaqualifiedgold
did not reach statistical significancep=0.1733.5× alphaplainly factual
In diabetic patients (n=17, 21%) the correlations of cfPWV with both fetuin-A and OPG did not reach statistical significance (p=0.173 and p=0.177 respectively) (Figure 2 a and 2 b), while in non-diabetic patients (n=64, 79%) the above correlations were highly significant (p=0.007 and p<0.001 respectively) (Figure 2 c and 2 d).
Two different doses of galnon (5 mg/kg, n = 9; 10 mg/kg, n = 9) induced robust CPP on the first post-test; saline-injected mice, irrespective of morphine pre-treatment, did not exhibit any preference for the conditioned compartment; this trend was also seen in the lowest dose galnon group (0.5 mg/kg, n = 9), though this effect did not reach statistical significance (treatment: F (4, 39) = 4.118, p = 0.007; test day: F (2, 78) = 5.582, p = 0.007; treatment × test day: F (8, 78) = 2.214, p = 0.035.
a strong trendP = 0.0070.1× alphagold
Following that, the DESTINY-Breast03 ( NCT03529110 ) phase III trial found that T-DXd as a second-line treatment for patients with HER2-positive MBC significantly improved PFS and had a strong trend of OS benefit (HR, 0.55; 95% CI, 0.36 to 0.86; P = 0.007) when compared to T-DM1 (HR, 0.28; 95% CI, 0.22 to 0.37; P < 0.001) [ 14 ].
approached significancep = .0070.1× alpha
Results Significantly higher ( U = 253863, p < .001) FMS total scores were found for recruits (mean 15.23 ± SD 2.01 points) when compared to attested officers (14.57 ± 2.96 points) and differences in FMS total scores also approached significance for females (15.24 ± 2.35 points) when compared to males (14.84 ± 2.55 points, U = 186926, p = .007), with age found to be a key, significant factor in explaining these observed differences (F (1,1507) = 23.519, p < .001).